About Zynex, Inc.
https://www.zynex.comZynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
CEO
Thomas Sandgaard
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-01-05 | Forward | 11:10 |
| 2003-12-16 | Reverse | 1:40 |
ETFs Holding This Stock
Summary
Showing Top 3 of 15
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:1.24M
Value:$93.23K
VANGUARD GROUP INC
Shares:921.27K
Value:$69.1K
BLACKROCK, INC.
Shares:465.12K
Value:$34.88K
Summary
Showing Top 3 of 68
About Zynex, Inc.
https://www.zynex.comZynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $13.36M ▼ | $52.04M ▲ | $-42.91M ▼ | -321.21% ▼ | $-1.42 ▼ | $-43.91M ▼ |
| Q2-2025 | $22.29M ▼ | $25.52M ▼ | $-20.03M ▼ | -89.87% ▼ | $-0.66 ▼ | $-9.25M ▲ |
| Q1-2025 | $26.58M ▼ | $31.31M ▼ | $-10.4M ▼ | -39.12% ▼ | $-0.33 ▼ | $-12M ▼ |
| Q4-2024 | $45.97M ▼ | $36.55M ▲ | $-615K ▼ | -1.34% ▼ | $-0.02 ▼ | $850K ▼ |
| Q3-2024 | $49.97M | $35.99M | $2.38M | 4.77% | $0.07 | $4.91M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $13.26M ▼ | $45.32M ▼ | $86.69M ▲ | $-41.37M ▼ |
| Q2-2025 | $17.54M ▼ | $85.94M ▼ | $84.67M ▼ | $1.26M ▼ |
| Q1-2025 | $23.85M ▼ | $105.76M ▼ | $84.98M ▼ | $20.77M ▼ |
| Q4-2024 | $39.63M ▲ | $122.08M ▼ | $86.37M ▼ | $35.71M ▼ |
| Q3-2024 | $37.63M | $126.06M | $90.29M | $35.77M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-42.91M ▼ | $-6.31M ▼ | $-18K ▲ | $2.04M ▲ | $-4.28M ▲ | $-6.33M ▼ |
| Q2-2025 | $-20.03M ▼ | $-6.2M ▲ | $-29K ▲ | $-80K ▲ | $-6.31M ▲ | $-6.23M ▲ |
| Q1-2025 | $-10.4M ▼ | $-10.5M ▼ | $-168K ▲ | $-5.11M ▼ | $-15.78M ▼ | $-10.67M ▼ |
| Q4-2024 | $-615K ▼ | $2.44M ▼ | $-216K ▼ | $-228K ▲ | $2M ▼ | $2.23M ▼ |
| Q3-2024 | $2.38M | $7.07M | $-72K | $-268K | $6.73M | $7M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Device | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 Supplies | $30.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
CEO
Thomas Sandgaard
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-01-05 | Forward | 11:10 |
| 2003-12-16 | Reverse | 1:40 |
ETFs Holding This Stock
Summary
Showing Top 3 of 15
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:1.24M
Value:$93.23K
VANGUARD GROUP INC
Shares:921.27K
Value:$69.1K
BLACKROCK, INC.
Shares:465.12K
Value:$34.88K
Summary
Showing Top 3 of 68